Drimva

AstraZeneca

Oncology Field Reimbursement Manager - Pennsylvania

$182K–$243K

US - PIttsburgh - PA +1 · Manager · Full-time · Posted Oct 8, 2026

Location
US - PIttsburgh - PA
US - Erie - PA
Experience
At least 5 years of business experience in healthcare, pharmaceuticals or biotechnology, including at least 2 years in pharmaceutical sales, managed care or reimbursement.
Education
Bachelor’s degree

About the job

Advises oncology practices and health systems across Pennsylvania (excluding Philadelphia) on reimbursement and access challenges, developing compliant strategies to help patients start and stay on treatment.

What you'll do

  • Advise priority accounts on reimbursement, coverage, payer requirements and access pathways for AstraZeneca oncology products.
  • Diagnose account and market barriers, then recommend practical, compliant solutions and territory strategies.
  • Educate providers and internal partners, manage territory resources and reporting, and share reimbursement insights across teams.

What they ask for

  • Bachelor’s degree and at least 5 years of business experience in healthcare, pharmaceuticals or biotechnology, including at least 2 years in pharmaceutical sales, managed care or reimbursement.
  • Command of reimbursement mechanisms, medical and pharmacy benefits, payer policy, utilization management, and applicable legal and regulatory requirements.
  • Track record of diagnosing access barriers and translating complex coverage requirements into practical, compliant guidance.
  • Ability to support the Pennsylvania territory, excluding Philadelphia, and travel as business needs require; residence within or ability to effectively support this geography is required.

Nice to have

  • Field reimbursement or managed-markets expertise in oncology, specialty medicine or physician-administered products.
  • Experience advising health systems, infusion centers, community practices or specialty networks on buy-and-bill and other access pathways.

Pay

$181,856 - $242,785 (base salary)

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)